CompletedNot applicableNCT01673269

Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Texas Tech University Health Sciences Center, El Paso
Principal Investigator
Mohamed O Othman, MD, M.D
Texas Tech University at El Paso
Intervention
Blood culture ( aerobic and anaerobic)(other)
Enrollment
60 target
Eligibility
18-80 years · All sexes
Timeline
2012 – 2013

Study locations (1)

Collaborators

American College of Gastroenterology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01673269 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials